-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bq9oCwCRkwWBOHA/rIs+ShoF4IyzrIQ0yw3fjdQQPEH0L2W/ZhADuzoh70Q7CDng hq8Zi05fi3z5y435/x0Qhw== 0000897101-03-000259.txt : 20030401 0000897101-03-000259.hdr.sgml : 20030401 20030401165027 ACCESSION NUMBER: 0000897101-03-000259 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030401 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20030401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ST JUDE MEDICAL INC CENTRAL INDEX KEY: 0000203077 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411276891 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12441 FILM NUMBER: 03634805 BUSINESS ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 BUSINESS PHONE: 6514832000 MAIL ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 8-K 1 stjude031565_8k.txt ST. JUDE MEDICAL INC. FORM 8-K 4/01/2003 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2003 ------------- ST. JUDE MEDICAL, INC. ---------------------- (Exact name of registrant as specified in its chapter) Minnesota 0-8672 41-1276891 ---------- ------- ---------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) One Lillehei Plaza, St. Paul, MN 55117 -------------------------------- ----- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (651) 483-2000 -------------- Not applicable -------------- (Former name or former address, if changed since last report) Item 9. Regulation FD Disclosure. ------------------------- On April 1, 2003 the Company completed the acquisition of Getz Bros. Co. Ltd., the largest distributor of the Company's products in Japan. The Company paid 26.9 billion Yen to acquire 100% of the common stock of Getz, which has approximately 400 employees. The Company predicts that the acquisition will be neutral to earnings per share in 2003 and accretive in 2004 and thereafter. As part of the financing for the acquisition the Company obtained an unsecured loan for 24.6 billion Yen. Separately, the Company has acquired the assets from Getz Bros. & Co. (Aust) Pty. Limited and Medtel Pty. Limited related to the distribution of the Company's products in Australia. Under this transaction the Company now employs approximately 30 additional sales and support employees in Australia and directly distributes all of its products in Australia. The prediction regarding the impact of the Getz Japan acquisition on earnings per share is a forward looking statement which is subject to risks and uncertainties, such as items described in the Financial Section of the Company's Annual Report to Shareholders for the fiscal year ending December 31, 2002 (see pages 6 - 8 of the Financial Report). Actual results may differ materially from anticipated results. SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ST. JUDE MEDICAL, INC. Date: April 1, 2003 By: /s/ Kevin T. O'Malley ------------- ---------------------- Kevin T. O'Malley Vice President and General Counsel -----END PRIVACY-ENHANCED MESSAGE-----